Mr. Ciamacco is a seasoned innovator in the medical stent and catheter space…His portfolio is important for companies involved in interventional cardiology, vascular surgery, stents, guidewires, and balloon catheters.
New York, NY (PRWEB) September 29, 2015
ICAP Patent Brokerage announces for sale patents disclosing a medical implantable stent and guidewire delivery and deployment system. This portfolio is available from Sam Ciamacco as part of the Cardiovascular Patent Auction. The brokerage continues to accept technology submissions for the auction, which will have a bidding deadline of December 10, 2015.
Sam Ciamacco, the sole inventor of the portfolio, is an experienced medical device engineer with experience in coronary angioplasty catheters, neurovascular catheters, and intravascular stents. He has worked or otherwise provided services to Medtronic Vascular as an R&D Engineer for new product development, for Medgination which became X-Technologies and was later acquired by Guidant, and for YMed which was acquired by Bard. See the inventor biography for Mr. Ciamacco.
“Mr. Ciamacco is a seasoned innovator in the medical stent and catheter space providing a meaningful IP offering to the public,” says Dean Becker, CEO of ICAP Patent Brokerage. “His portfolio is important for companies involved in interventional cardiology, vascular surgery, stents, guidewires, and balloon catheters.”
Mr. Ciamacco’s technology may be applied to any stent regardless of the construction material used (bare metal, drug eluting, self-expanding nitinol, polymer, bio-absorbable, etc.) in fabricating the stent or the delivery system. Mr. Ciamacco’s technology is intended to be a Rapid Exchange (RX) or Single Operator Exchange (SOE) platform. Such technology may allow any partner with limited access to the U.S. market (because of limited IP or their existing Over the Wire (OTW) systems) the opportunity to compete within the United States.
Mr. Ciamacco plans to present these technologies to the public on a live conference call to the market on October 1st, 2015 at 12:00 PM EST. Individuals who wish to listen in or participate anonymously during the call may dial (310)971-9099, and are encouraged to submit questions directed to Mr. Ciamacco before the call by emailing Michelle Tyler below.
Mr. Ciamacco has indicated that he is willing to serve as a consultant in providing product design consulting to any entity who acquires his technologies, subject to reasonable and mutually agreeable terms.
See the technical description of the stent and guidewire delivery and deployment system IP sales offering.
Sample forward or rearward citing companies include Medtronic Vascular, Inc.
To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (312) 327-4438 or via email at firstname.lastname@example.org.
If you have a patent portfolio for sale, visit our website to make a patent portfolio submission for an upcoming sealed bid event.
About ICAP Patent Brokerage
ICAP Patent Brokerage is the world's largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.